News
Hosted on MSN1mon
Targeted alpha therapy: Advances in treating refractory skin cancerWe found a dose-dependent inhibitory effect in a melanoma-bearing mouse model, confirming the effectiveness of our approach." The findings were remarkable. The [211 At]NpG-GGN4c showed high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results